Home > Press > Northeastern receives $13.5M award for Center of Cancer Nanotechnology Excellence
 |
| Distinguished Professor Vladimir Torchilin will lead the new Center for Translational Cancer Nanomedicine. Photo by Mary Knox Merrill. |
Abstract:
Northeastern University has been designated as a Center of Cancer Nanotechnology Excellence funded by a highly competitive, five-year, $13.5 million grant from the National Institutes of Health's National Cancer Institute (NCI). The University will establish the Center for Translational Cancer Nanomedicine where a multidisciplinary team of scientists, industry and government partners will develop cancer treatments from discovery to delivery.
Northeastern receives $13.5M award for Center of Cancer Nanotechnology Excellence
Boston, MA | Posted on September 29th, 2010
Through the new Center—included in the second phase of the NCI's Alliance for Nanotechnology in Cancer program—Northeastern researchers will create new drugs that target cancer cells, advance technology on how nanocarriers deliver these drugs, and utilize imaging tools that track how they travel through the body.
"The idea is that a lot of people are doing excellent research in the field of nanomedicine, but in 95 percent of the cases this research ends with a good publication," said Vladimir Torchilin, distinguished professor and director of the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern's Bouvé College of Health Sciences. "The most difficult part is the next step—if you have good results, how do you turn those results into products?"
Led by Torchilin, the new Center's research and development partnership includes Beth Israel Deaconess Medical Center/Harvard Medical School and Auburn University. The partners will work together to develop a continuous path from basic research to industrial production of cancer nanomedicines—thereby narrowing the gap between discovery and early development of cancer therapeutics and diagnostics.
In addition to the Center of Excellence designation, the Alliance has awarded Northeastern distinguished professor Mansoor Amiji with a five-year, $2.32 million grant as part of the Cancer Nanotechnology Platform Partnership program. Amiji, chair of the Department of Pharmaceutical Sciences in Bouve's School of Pharmacy, will collaborate with researchers at Massachusetts General Hospital to develop treatment for multidrug resistant forms of lung and ovarian cancer. The work involves using nanoparticles and gene silencing techniques to more efficiently target tumors and reverse their resistance to anti-cancer therapies. The researchers will also create a library of nanoparticles they can screen and select from when treating various forms of cancer.
"This is an extraordinary accomplishment for Vladimir and his team, and it is well deserved recognition of the quality of his research," said Stephen Zoloth, dean of Bouvé, which is home to several centers focusing on biotechnology, nanomedicine, drug discovery, and public health research. "It is centers of excellence like these that make Northeastern a hub of translational research that can lead to breakthroughs in cancer diagnosis and treatment."
The new Center will help accelerate the momentum of use-inspired research leading to important discoveries in health—one of three Northeastern research themes, including security and sustainability, aimed at solving pressing global challenges.
"It is the responsibility of leading research universities to solve the greatest challenges of our time," said Joseph E. Aoun, president of Northeastern University. "Northeastern has been at the forefront of nanotechnology innovation and discovery in several areas of global significance. With this new center we are taking research at the frontiers of medical science to the next level."
####
About Northeastern University
Northeastern University is home to a strong base of interdisciplinary nanotechnology research, and is an ideal location for this new Center, which will collaborate with other centers of nanotechnology research. The George J. Kostas Nanoscale Technology and Manufacturing Research Center at Northeastern is part of the University’s Center for High-Rate Nanomanufacturing, as well as the Center for Translational NeuroImaging and the IGERT Nanomedicine Science and Technology program will all work together in partnership with the new Center, which will also include an educational outreach component.
For more information, please click here
Contacts:
Greg St.Martin
617-373-5463
Copyright © Northeastern University
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Imaging
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Govt.-Legislation/Regulation/Funding/Policy
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013
An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Academic/Education
CNSE Welcomes Record Number of Students, Majority of Whom are New Yorkers, for Prestigious Summer Internship Program June 12th, 2013
FEI and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs: Collaboration effort will focus on new methods to classify shales in the economic assessment of “tight” resource plays June 7th, 2013
Johannes Gutenberg University Mainz obtains new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" June 2nd, 2013
Lorraine University uses Nanoparticle Tracking Analysis to characterize biomolecules for agrichemicals, pharmacology and cosmetics May 28th, 2013
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013